Dyne Therapeutics, Inc. - COMMON STOCK (DYN)

CUSIP: 26818M108

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / COMMON STOCK
Shares outstanding
164,064,426
Total 13F shares
155,774,921
Share change
+27,199,325
Total reported value
$1,970,440,035
Put/Call ratio
132%
Price per share
$12.65
Number of holders
205
Value change
+$381,733,004
Number of buys
146
Number of sells
64

Quarterly Holders Quick Answers

What is CUSIP 26818M108?
CUSIP 26818M108 identifies DYN - Dyne Therapeutics, Inc. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Dyne Therapeutics, Inc. - COMMON STOCK (DYN) as of Q3 2025

As of 30 Sep 2025, Dyne Therapeutics, Inc. - COMMON STOCK (DYN) was held by 205 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 155,774,921 shares. The largest 10 holders included JANUS HENDERSON GROUP PLC, VANGUARD GROUP INC, BlackRock, Inc., Atlas Venture Life Science Advisors, LLC, FCPM III SERVICES B.V., FMR LLC, STATE STREET CORP, Siren, L.L.C., TCG Crossover Management, LLC, and ADAGE CAPITAL PARTNERS GP, L.L.C.. This page lists 205 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.